Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group-Reference-Cited by-同舟云学术

Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group

Published:2020-08 Issue:4 Volume:3 Page:455-463
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

O'Sullivan Joe M.,Carles Joan,Cathomas Richard,Gomez-Iturriaga Alfonso,Heinrich Daniel,Kramer Gero,Ost Piet,van Oort Inge,Tombal Bertrand

Funder

Bayer

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference64 articles.

1. Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer;Fizazi;N Engl J Med,2017

2. Abiraterone for prostate cancer not previously treated with hormone therapy;James;N Engl J Med,2017

3. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial;James;Lancet,2016

4. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer;Sweeney;N Engl J Med,2015

5. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial;Parker;Lancet,2018

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer;eClinicalMedicine;2023-06

2. Management of bone metastasis in prostate cancer;Journal of Bone and Mineral Metabolism;2023-05

3. Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer;Frontiers in Medicine;2022-12-22

4. Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study);Prostate Cancer and Prostatic Diseases;2022-02-21

5. Bone health and therapeutic agents in advanced prostate cancer;Frontiers in Bioscience-Landmark;2022-01-18